NOVATO, Calif.– QT Imaging Holdings, Inc. (OTCQB: QTIH), a medical device company developing innovative body imaging systems, said Wednesday it has received $5 million in new financing from Lynrock Lake Master Fund LP through a restated and amended senior secured term loan.
Proceeds from the transaction were used to repurchase in full the warrants held by YA II PN, Ltd. (Yorkville), representing 15 million shares of QT Imaging common stock at an exercise price of $0.40 per share. The warrants have now been canceled.
“This transaction reflects our confidence in the future outlook of our business,” said Raluca Dinu, Ph.D., CEO of QT Imaging. “We would like to thank our investors and partners at Lynrock Lake for their continuing support and flexibility to make this repurchase and cancellation possible. We believe the current valuation of QT Imaging stock makes this an attractive investment and an opportunity to enhance long-term shareholder value.”
QT Imaging develops medical imaging systems using low-frequency sound waves designed to improve safety, affordability, and accessibility in diagnostics. The company is focused on advancing patient-centered imaging technologies that can play a critical role in disease detection, diagnosis, and treatment.